Even when all regulatory requirements are formally met, French documents can still fall short, not scientifically but linguistically. QRD compliance is often assumed to guarantee clarity and clinical usability, yet this assumption does not always hold true. Regulatory standards provide a non-negotiable foundation, but they do not prevent ambiguous, awkward or linguistically inappropriate phrasings. A French SmPC may fully comply with QRD requirements, implement EDQM terminology and reference regulatory dictionaries correctly, while still creating confusion in clinical practice.
At this point, regulatory translation transcends linguistic transfer and becomes a form of linguistic risk management. True quality is achieved only when regulatory compliance, terminology precision and clinical readability are aligned; a balance that is demanding, but entirely achievable: a document can be both fully compliant and idiomatically correct, even if absolute perfection is neither realistic nor required.
In addition, uncritical adherence to predefined glossaries established by certain pharmaceutical stakeholders is insufficient when medical context, target audience, document type or regulatory framework are not fully considered. Inconsistencies in the source document inevitably carry over into the target document, impacting consistency and credibility. Linguistic expertise grounded in both solid medical and regulatory knowledge plays a key role in safeguarding terminology choices and mitigating these risks. Nevertheless, glossaries remain essential tools when used with contextual awareness and scientific judgement.
Ultimately, the core challenge lies in ensuring strict regulatory compliance while maintaining clinical readability and avoiding literal translation. In submissions to European authorities, terminology precision is not merely cosmetic, it is essential for credibility and safety. Regulatory French is a discipline in its own right, and recognizing it as such contributes directly to clearer, safer and more reliable regulatory documentation.
This article reflects my perspective on regulatory medical translation and writing as part of a broader process of linguistic risk management, in which linguistic precision and terminology management contribute to the overall credibility of documentation. When terminology issues raise regulatory or safety concerns, early discussion can often prevent subsequent complications. I welcome discussions with professionals facing such challenges and would be happy to offer guidance.
Written by Dr. Farah AYADI
Reviewed by Mr. Stephen O'Sullivan
